NASDAQ:SLP Simulations Plus (SLP) Stock Price, News & Analysis $18.48 -0.01 (-0.03%) As of 11:38 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Simulations Plus Stock (NASDAQ:SLP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Simulations Plus alerts:Sign Up Key Stats Today's Range$18.47▼$18.4850-Day Range$18.23▼$18.4852-Week Range$11.09▼$21.01Volume142,174 shsAverage Volume352,103 shsMarket Capitalization$373.75 millionP/E Ratio46.19Dividend YieldN/APrice Target$17.25Consensus RatingReduce Company Overview Simulations Plus, Inc. develops software and provides consulting services for pharmaceutical and biotechnology companies involved in drug discovery and development. Its modeling and simulation tools are designed to help researchers evaluate drug candidates, understand how medicines move through the body, assess safety risks and support decisions throughout the development process. The company’s products include GastroPlus, a platform used for physiologically based pharmacokinetic and biopharmaceutic modeling; ADMET Predictor, which helps predict absorption, distribution, metabolism, excretion and toxicity characteristics; and DILIsym, a software platform focused on drug-induced liver injury. Simulations Plus also offers additional modeling tools and scientific services covering pharmacokinetics, pharmacodynamics, toxicology and related areas. Founded in 1996, Simulations Plus serves pharmaceutical and biotechnology companies, contract research organizations, regulatory agencies and academic institutions. Its customer base is international, reflecting the company’s role in supporting drug research and development across major global pharmaceutical markets.AI Generated. May Contain Errors. Read More Simulations Plus Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreSLP MarketRank™: Simulations Plus scored higher than 16% of companies evaluated by MarketBeat, and ranked 838th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.1 / 5Analyst RatingReduce Consensus RatingSimulations Plus has received a consensus rating of Reduce. The company's average rating score is 1.88, and is based on no strong buy ratings, no buy ratings, 7 hold ratings, and 1 sell rating.Downside RiskSimulations Plus has a consensus price target of $17.25, representing about 6.6% downside from its current price of $18.47.Amount of Analyst CoverageSimulations Plus has only been the subject of 1 research reports in the past 90 days.Read more about Simulations Plus' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Simulations Plus is 46.19, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.77.Price to Earnings Ratio vs. SectorThe P/E ratio of Simulations Plus is 46.19, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.16.Price to Book Value per Share RatioSimulations Plus has a P/B Ratio of 2.98. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Simulations Plus' valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted17.68% of the float of Simulations Plus has been sold short.Short Interest Ratio / Days to CoverSimulations Plus has a short interest ratio ("days to cover") of 14.81, which indicates bearish sentiment.Change versus previous monthShort interest in Simulations Plus has recently increased by 1.97%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSimulations Plus does not currently pay a dividend.Dividend GrowthSimulations Plus does not have a long track record of dividend growth. News and Social Media3.8 / 5News Sentiment1.12 News SentimentSimulations Plus has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Simulations Plus this week, compared to 4 articles on an average week.Search Interest3 people have searched for SLP on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows3 people have added Simulations Plus to their MarketBeat watchlist in the last 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Simulations Plus insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $95,384.00 in company stock.Percentage Held by Insiders19.10% of the stock of Simulations Plus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions78.08% of the stock of Simulations Plus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Simulations Plus' insider trading history. Receive SLP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Simulations Plus and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLP Stock News HeadlinesSimulations Plus, Inc. (NASDAQ:SLP) Stock Has Average Price Target of $17.25September 25, 2026 | americanbankingnews.comCritical Analysis: Maravai LifeSciences (NASDAQ:MRVI) vs. Simulations Plus (NASDAQ:SLP)September 22, 2026 | americanbankingnews.comA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.September 30 at 1:00 AM | TradeSmith (Ad)Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET PredictorSeptember 18, 2026 | finance.yahoo.comSimulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science BranchSeptember 17, 2026 | businesswire.comJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting DisclosuresSeptember 10, 2026 | globenewswire.comJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting DisclosuresAugust 27, 2026 | globenewswire.comJohnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting DisclosuresAugust 20, 2026 | globenewswire.comSee More Headlines SLP Stock Analysis - Frequently Asked Questions How have SLP shares performed this year? Simulations Plus' stock was trading at $18.23 at the beginning of 2026. Since then, SLP stock has increased by 1.3% and is now trading at $18.4710. How were Simulations Plus' earnings last quarter? Simulations Plus, Inc. (NASDAQ:SLP) issued its quarterly earnings results on Thursday, July, 9th. The technology company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.07. The technology company had revenue of $21.89 million for the quarter, compared to analysts' expectations of $20.90 million. Simulations Plus had a trailing twelve-month return on equity of 13.50% and a net margin of 9.88%. How do I buy shares of Simulations Plus? Shares of SLP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Simulations Plus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Simulations Plus investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings7/09/2026Today9/30/2026Next Earnings (Estimated)10/29/2026Fiscal Year End8/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 SLP's financial health is in the Green zone, according to TradeSmith. SLP has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:SLP CIK1023459 Webwww.simulations-plus.com Phone(661) 723-7723Fax661-723-5524Employees213Year Founded1996Price Target and Rating Average Price Target for Simulations Plus$17.25 High Price Target$18.50 Low Price Target$16.00 Potential Upside/Downside-6.6%Consensus RatingReduce Rating Score (0-4)1.88 Research Coverage8 Analysts Profitability EPS (Trailing Twelve Months)$0.40 Trailing P/E Ratio46.19 Forward P/E RatioN/A P/E GrowthN/ANet Income-$64.72 million Net Margins9.88% Pretax Margin15.30% Return on Equity13.50% Return on Assets12.45% Debt Debt-to-Equity RatioN/A Current Ratio5.54 Quick Ratio5.54 Sales & Book Value Annual Sales$79.18 million Price / Sales4.72 Cash Flow$1.43 per share Price / Cash Flow12.91 Book Value$6.20 per share Price / Book2.98Miscellaneous Outstanding Shares20,230,000Free Float16,362,000Market Cap$373.75 million OptionableOptionable Beta1.33 Social Links 10 Best Stocks to Own: Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:SLP) was last updated on 9/30/2026 by MarketBeat.com Staff. From Our PartnersDr. Ron Paul Issues New Warning: “The Next Financial Crisis Is Here”Dr. Ron Paul warns a dangerous experiment is already underway in Washington, involving at least 27 billion dol...Altimetry | SponsoredA Little Known Explorer Sits Near Major Gold DepositsBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...Wall Street Logic | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredShould You Convert a Traditional IRA to a Roth After 60?Considering a Roth conversion after 60? The upside includes no income limits on conversions, potential tax-fre...SmartAsset | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simulations Plus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Simulations Plus With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
